Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment of dyspnea. Low-dose oral or sublingual opioids are effective in treating dyspnea.

[1] While therapies for the treatment of dyspnea in end-stage CF lung disease are limited, case reports of its effective treatment with inhaled opioids have been published. However, the use of ...

Medically reviewed by Michael Menna, DO Fact checked by Maddy Simpson Shortness of breath, also called dyspnea, has many ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.